Boston Scientific Corp's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Total-Revenue" stands at 19.35 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.
Boston Scientific Corp's third quarter result of 5.06 Billion USD for the item "Total Revenue" represents an increase of 0.08 percent compared to it's second quarter result.
Also, Boston Scientific Corp's third quarter result of 5.06 Billion USD for the item "Total Revenue" represents an increase of 20.34 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Boston Scientific Corp's third quarter result of 19.35 Billion USD for the item "Total Revenue" represents an increase of 4.63 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 21.62 percent compared to the value the year prior.
The 1 year change in percent is 21.62.
The 3 year change in percent is 53.97.
The 5 year change in percent is 91.39.
The 10 year change in percent is 161.98.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Abbott Laboratories - Total Revenue | 217,696,616,448.00 |
![]() | Intuitive Surgical Inc - Total Revenue | 206,245,888,000.00 |
![]() | EssilorLuxottica S. A. - Total Revenue | 172,241,486,586.05 |
![]() | Danaher Corporation - Total Revenue | 162,006,663,168.00 |
![]() | Stryker Corporation - Total Revenue | 139,209,850,880.00 |